Panel can detect multiple variants of the SARS-CoV-2 virus, including those most recently identified in the United Kingdom, South Africa,
Read moreLEXINGTON, Mass., Jan. 07, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a global leader in the rapid detection of sepsis-causing
Read moreLEXINGTON, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens,
Read moreTotal revenues increase by 213% on record high quarterly product sales LEXINGTON, Mass., Nov. 04, 2020 (GLOBE NEWSWIRE) — T2
Read moreJohn Sperzel will serve on the Industry Council of the Advisory Board LEXINGTON, Mass. and SAN DIEGO, Oct. 19, 2020
Read moreLEXINGTON, Mass., Oct. 14, 2020 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens,
Read moreLEXINGTON, Mass., Oct. 14, 2020 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens,
Read moreAdvances Development of Diagnostics for Sepsis-Causing Pathogens, Antibiotic Resistance, and Biothreat Pathogens LEXINGTON, Mass., Sept. 30, 2020 (GLOBE NEWSWIRE) —
Read moreAdvances Development of Diagnostics for Sepsis-Causing Pathogens, Antibiotic Resistance, and Biothreat Pathogens LEXINGTON, Mass., Sept. 30, 2020 (GLOBE NEWSWIRE) —
Read moreAdvances Development of Diagnostics for Sepsis-Causing Pathogens, Antibiotic Resistance, and Biothreat Pathogens LEXINGTON, Mass., Sept. 30, 2020 (GLOBE NEWSWIRE) —
Read more